QX005N

PN

Phase III

Phase llI clinical trial of QX005N for PN

QX013N

CSU

Phase I

Phase I clinical trial of QX013N for CSU

QX005N

adolescent AD

Phase II

Phase II clinical trial of QX005N for adolescent AD

QX005N

Moderate to severe AD

Phase llI

Phase llI clinical trial of QX005N for AD

QX005N

CRSwNP

Phase II

Extended Phase II Clinical Trial of QX005N for CRSwNP

QX004N

Adult moderate to severe plaque Ps

Phase II

Phase II clinical trial of QX004N for Adult moderate to severe plaque Ps

QX002N

AS

Phase III

Phase III clinical trial of QX002N for AS